- Dabur India reported a third-quarter retail revenue of 326.1 million rupees.
- This retail revenue exceeded analyst estimates of 301.2 million rupees.
- The consumer care segment generated a revenue of 28.50 billion rupees.
- The food segment contributed 4.30 billion rupees in revenue.
- Analyst recommendations for Dabur India include 24 buy ratings, 17 hold ratings, and 3 sell ratings.
A look at Dabur India Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Dabur India Ltd. appears to have a mixed long-term outlook according to the Smartkarma Smart Scores. The company scores well in dividend and resilience, indicating a strong performance in these areas. With a score of 4 for dividends, investors can expect consistent returns in the form of dividends over time. Additionally, a resilience score of 4 suggests that Dabur India Ltd. is well-equipped to withstand economic downturns and market volatility.
However, the company’s scores for value, growth, and momentum are more moderate, with scores of 2, 3, and 3 respectively. This indicates that while Dabur India Ltd. may not be considered undervalued, it has shown steady growth and maintained a reasonable level of momentum. Overall, Dabur India Ltd. seems to offer a sound investment opportunity based on its strong performance in dividends and resilience, coupled with steady growth and momentum.
Summary: Dabur India Ltd.
Dabur India Ltd. manufactures soaps, detergents, hair oils, tooth powders, antacids, and processed foods, selling its products worldwide.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
